Despite the fact that UCB is easily accessible and associated with lower rates of graft versus host disease (GVHD), insufficient quantities of whole nucleated cells and CD34+ cell dosage forms in UCB units cause delayed hematopoietic healing and increased rates of graft failure, which tend to increase the infection rate. Here, CD34 is linked to infection.